Imricor Medical Systems, Inc. (ASX:IMR)
Australia
· Delayed Price · Currency is AUD 1.940
-0.060 (-3.00%)
At close: Mar 9, 2026
Imricor Medical Systems Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -25.32 | -29.69 | -22.63 | -17.36 | -19.73 | Upgrade
|
| Depreciation & Amortization | 1 | 0.92 | 0.86 | 0.93 | 0.69 | Upgrade
|
| Other Amortization | - | - | 0.01 | 0.1 | - | Upgrade
|
| Loss (Gain) From Sale of Assets | 0.03 | -0 | 0 | 0 | 0.08 | Upgrade
|
| Stock-Based Compensation | 0.59 | 0.07 | 0.54 | 0.32 | 1.15 | Upgrade
|
| Other Operating Activities | 4.03 | 11.18 | 6.34 | 0.69 | 0.71 | Upgrade
|
| Change in Accounts Receivable | 0.15 | 0.07 | -0.22 | -0.07 | 0.15 | Upgrade
|
| Change in Inventory | -0.13 | 0.45 | -0.92 | -0.44 | -0.18 | Upgrade
|
| Change in Accounts Payable | 0.04 | -1.75 | 1.91 | -0.4 | 0.15 | Upgrade
|
| Change in Unearned Revenue | -0.04 | -0.22 | 0.86 | -0.17 | 0.09 | Upgrade
|
| Change in Other Net Operating Assets | 0.57 | 3.4 | 0.27 | -0.11 | -0.61 | Upgrade
|
| Operating Cash Flow | -19.08 | -15.57 | -12.98 | -16.51 | -17.49 | Upgrade
|
| Capital Expenditures | -0.43 | -0.08 | -0.08 | -0.24 | -0.63 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0 | - | - | - | Upgrade
|
| Investment in Securities | -21.28 | - | - | - | -0.07 | Upgrade
|
| Investing Cash Flow | -21.71 | -0.07 | -0.08 | -0.24 | -0.7 | Upgrade
|
| Long-Term Debt Issued | - | 0.34 | 3.31 | 3.16 | - | Upgrade
|
| Long-Term Debt Repaid | -0.21 | -1.01 | -0.84 | -1.2 | -0.58 | Upgrade
|
| Net Debt Issued (Repaid) | -0.21 | -0.67 | 2.46 | 1.97 | -0.58 | Upgrade
|
| Issuance of Common Stock | 44.57 | 32.91 | 5.85 | 2.05 | 12.17 | Upgrade
|
| Other Financing Activities | -1.31 | -1.91 | -0.1 | -0.07 | - | Upgrade
|
| Financing Cash Flow | 43.05 | 30.33 | 8.21 | 3.94 | 11.59 | Upgrade
|
| Foreign Exchange Rate Adjustments | 1.54 | 0.19 | -0.01 | -0.02 | -0.03 | Upgrade
|
| Net Cash Flow | 3.79 | 14.88 | -4.86 | -12.83 | -6.62 | Upgrade
|
| Free Cash Flow | -19.52 | -15.65 | -13.06 | -16.75 | -18.11 | Upgrade
|
| Free Cash Flow Margin | -6676.31% | -1631.38% | -2121.66% | -2052.56% | -2601.63% | Upgrade
|
| Free Cash Flow Per Share | -0.06 | -0.07 | -0.08 | -0.12 | -0.14 | Upgrade
|
| Cash Interest Paid | 0 | 0.02 | 0.05 | 0.07 | 0.18 | Upgrade
|
| Levered Free Cash Flow | -9.17 | -10.41 | -6.08 | -10.6 | -11.34 | Upgrade
|
| Unlevered Free Cash Flow | -9.17 | -10.4 | -6.06 | -10.59 | -11.27 | Upgrade
|
| Change in Working Capital | 0.59 | 1.95 | 1.9 | -1.2 | -0.39 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.